Please note that Internet Explorer is incompatible with this site.

We recommend upgrading to the latest Microsoft Edge, Google Chrome, or Firefox.

Skip to Main Content

Neurology

Department of Neurology

John Ciotti, MD

John Ciotti, MD

Assistant Professor, Neurology, Multiple Sclerosis Division

Contact Info 13330 USF Laurel Drive
Tampa FL 33612

Academic Phone:8133969478

Education

  • MSCI, Clinical Investigation, Washington University in St. Louis, 2022
  • MD, Multiple Sclerosis Fellowship, Washington University in St. Louis, 2021
  • MD, Neurology Residency, Washington University in St. Louis, 2019
  • MD, Medicine, Florida Atlantic University, 2015
  • BS, Biology, University of Florida, 2010
  • BA, Economics, University of Florida, 2010

Recent Publications

  • Stefan KA, Ciotti JR. MOG antibody disease: nuances in presentation, diagnosis, and management. Current Neurology and Neuroscience Reports. doi: 10.1007/s11910-024-01344-z, 2024.
  • Brier MR, Xiang B, Ciotti JR, Chahin S, Wu GF, Naismith RT, Yablonskiy D, Cross AH. Quantitative MRI identifies lesional and non-lesional abnormalities in MOGAD. Multiple Sclerosis and Related Disorders. 73: 104659, 2023.
  • Kolli A, Ciotti J. Updates in Bruton's tyrosine kinase inhibition for multiple sclerosis. Practical Neurology. 22(2) , 2023.
  • Lambe J, McGinley MP, Moss BP, Mao-Draayer Y, Kassa R, Ciotti JR, Mariotto S, Kunchok A. Myelin oligodendrocyte glycoprotein-IgG associated disorders (MOGAD) following SARS-CoV-2 infection: A case series. Journal of Neuroimmunology. 370: 577933, 2022.
  • Ciotti JR, Perantie DC, Moss BP, Fitzgerald KC, Cohen JA, Mowry EM, Naismith RT, Chahin S. Perspectives and experiences with COVID-19 vaccines in people with MS. Multiple Sclerosis Journal - Experimental, Translational and Clinical. 8(1) : 20552173221085242, 2022.
  • Ciotti JR, Eby NS, Brier MR, Wu GF, Chahin S, Cross AH, Naismith RT. Central vein sign and other radiographic features distinguishing myelin oligodendrocyte glycoprotein antibody disease from multiple sclerosis and aquaporin-4 antibody-positive neuromyelitis optica. Multiple Sclerosis Journal. 28(1) : 49-60, 2022.
  • Ciotti JR, Grebenciucova E, Moss BP, Newsome SD. Multiple Sclerosis Disease-Modifying Therapies in the COVID-19 Era. Annals of Neurology. 88(6) : 1062-1064, 2020.
  • Ciotti JR, Valtcheva MV, Cross AH. Effects of MS disease-modifying therapies on responses to vaccinations: A review. Multiple Sclerosis and Related Disorders. 45: 102439, 2020.
  • Ciotti JR, Eby NS, Wu GF, Naismith RT, Chahin S, Cross AH. Clinical and laboratory features distinguishing MOG antibody disease from multiple sclerosis and AQP4 antibody-positive neuromyelitis optica. Multiple Sclerosis and Related Disorders. 45: 102399, 2020.
  • Ciotti JR, Sanders N, Salter A, Berger JR, Cross AH, Chahin S. Clinical instrument to retrospectively capture levels of EDSS. Multiple Sclerosis and Related Disorders. 39: 101884, 2019.
  • Ciotti JR, Cross AH. Disease-Modifying Treatment in Progressive Multiple Sclerosis. Current Treatment Options in Neurology. 20(5) : 12, 2018.

Awards/Honors

  • Sylvia Lawry Physician Fellowship (National MS Society - 2020)
  • Abdullah M. Nassief Award (Washington University in St. Louis - 2018)
  • Irwin Levy Resident Teaching Award (Washington University in St. Louis - 2018)
  • Gold Humanism Honor Society (Gold Humanism Honor Society - 2014)